One contribution of 11 to a Theme Issue 'Integrated cancer biology models'.
Biological research has long sought the predictability and precision inferred through mathematical modelling to better understand and explain both simple and complex natural phenomena. Mathematical insight has been essential for many advances in ecology, genetics and evolution, but has been less successful in describing more basic molecular, cellular and disease processes. While in silico models are critical components of more physically tractable scientific disciplines such as metrology and economics, biology has not fully embraced or integrated these more quantitative approaches into its research continuum. Beyond the inherent complexity of biology, there are a variety of reasons for this lag, including lack of appropriate datasets, ill-defined biological questions, inappropriate model application and often simple social separation of the disciplines. Advances in all of these areas are slowly changing this view to the benefit of modern biology and disease research.
The US National Cancer Institute (NCI) has a simple mission to understand the biology of cancer in order to better prevent, manage and treat the disease for the health of the nation and the world. To accomplish this mission, the NCI supports and conducts a broad range of research enterprises. Indeed, we have seen positive shifts within the USA in overall cancer incidence and death rates for some specific cancers. 1 Many of these shifts can be attributed to early detection and healthier lifestyles. Tremendous advances in the treatment of cancer have also been made with probably the most exciting advance in the area of targeted therapy. Despite this progress, cancer remains a serious problem with devastating impact at both a personal and societal level. Certain types of cancer and certain populations have not experienced the same advances, and resistance is emerging with some of our most promising drugs. Most sobering is the fact that cancer remains the leading cause of death worldwide, accounting for 7.6 million deaths (around 13% of all deaths) in 2008 [1] . The challenge is the complex nature of cancer and the purely reductionist approach that has advanced the field thus far. It is now well established that cancer is multiscale involving many processes at the molecular, cellular and organismal level. At a molecular level, there are a vast collection of mutations and signalling networks associated with cancer. At a cellular level, we are beginning to understand the complex milieu of different cell types and interactions that make up the tumour microenvironment and, finally, the many processes such as inflammation, angiogenesis and the immune response within the host. All of these processes work in a coordinated fashion to progress cancer through initiation, metastasis and intervention. Not only is each level a system unto itself but the systems act across scales in a well-coordinated and adaptive manner. Modern cancer biology recognizes this and grapples with the methodologies to take our understanding to the next level. To add to this complexity of scales is the vast amount of high-dimensional data and information that are being generated covering all aspects of a patient's cancer. The 'Omic' revolution is for the first time providing a comprehensive 'parts list' for our analysis. The challenge of course is how to make sense of this vast amount of information and complex interactions. Here is where we turn to & 2013 The Author(s) Published by the Royal Society. All rights reserved. mathematical modelling for the necessary structure and analytics to provide testable and predictive models to not only explain but also to probe the various mechanisms of cancer. Models, while not perfect and by their very nature wrong [2] , are becoming critical and necessary in modern cancer systems biology as they can be useful both for providing novel hypotheses and for driving experimentation that leads to a deeper understanding. Mathematical models are also a great tool for integrating multiple distinct processes/components of a system and bridging multiple spatial and temporal scales in ways that would be impossible for experimentation alone. Models can be roughly classified as descriptive or mechanistic and, importantly for this Theme Issue, models can also be used as a means to integrate data and extract crucial information from them.
The research community has realized this and has increasingly embraced systems biology and mathematical modelling in biomedical research. In 2004, the NCI began the Integrative Cancer Biology Program (ICBP) with the express purpose of developing these fields in the area of cancer biology. The ICBP is a large programme encompassing centres, individual research grants and educational activities, along with data infrastructure (http://icbp.nci.nih.gov/). At its core are the Centers for Cancer Systems Biology, which focus on the analysis of cancer as a complex biological system. The cornerstone of the programme is the development and implementation of mathematical and computational models of processes relevant to cancer prevention, diagnostics and therapeutics. The integration of experimental biology with mathematical modelling leads to new insights in cancer biology and innovative approaches to the management of cancer. The programme brings clinical and basic cancer researchers together with researchers from mathematics, physics, information technology, imaging sciences and computer science to work on key questions in cancer biology. The individual centres work both as multi-discipline research teams and as collaborative units in an overall consortium. The centres cover a broad range of issues in cancer biology from (epi)-genetics and signalling networks to cellular biology and clinical issues. The biological components are complemented by mathematical and computational modelling. While always present, throughout the life of the ICBP the importance of modelling has steadily increased with both novel approaches and applications being developed hand in hand with emerging experimental techniques and data acquisition. As members of this programme, we began to see a need to bring all of the theoreticians together to discuss our techniques and results and how best to apply (and/or integrate) them to the diverse datasets that were being generated.
This Theme Issue reflects the results of a series of workshops that began in Berkeley, CA, in October 2010 and finished in Tampa, FL, in March 2012, chaired by Claire Tomlin (UC Berkeley) and Alexander Anderson (Moffitt). The mathematics of the ICBP workshops brought together all of the mathematical and computational modellers across the 12 centres to galvanize a community that was already developing: mathematical oncology [3] . As part of the workshop participation, we asked each centre to provide a list of key questions that it considered critical to this new community. While there were many, some unifying questions emerged (Box 1) .
In addition to these questions, we saw some excellent presentations highlighting novel approaches to address them, which led us to ask for possible contributions to this Theme Issue of Interface Focus; from the initial 40 we obtained, we ultimately selected 10. These papers cover a diverse spectrum of both modelling techniques and application scales. Methods which are based on data clustering, segmentation and statistical regression methods have been used to organize and understand large biological datasets: the methods in Zhu et al. [4] use these to help pinpoint the vascular structures within breast cancer tumours; Gevaert et al. [5] used such methods in their tool AMARETTO to connect cancer drivers with their downstream targets. Yet other methods deal with clever ways to constrain parameter uncertainty: the paper by Hagen et al. [6] demonstrates that optimal experiment design may be used to achieve quantifiably accurate parameter estimation. Information theoretic and statistical methods for inferring and understanding biological pathways have found great promise in cancer systems biology: the paper by Jang et al. [7] demonstrates hARACNe, a tool based on the data-processing inequality from information theory and its use in inferring transcriptional regulatory networks; and the paper by Sachs et al. [8] demonstrates how perturbations combined with generalized Bayesian networks can be very effective in learning network structure. Differential equation-based models are ideal for capturing both spatial and temporal dynamics and can be used in a modular-like manner to connect distinct processes and scales, employed here by Wilkie & Hahnfeldt [9] to analyse the possible causative mechanisms of cancer escape from immune-induced dormancy. Parmar et al. [10] used a modular approach that incorporates the interaction of three cellular systems: the unfolded protein response, autophagy and apoptosis to better understand anti-oestrogen resistance. Single-cell-based models are ideal for examining interactions and characterizing the heterogeneous nature of tumours: Gallaher & Anderson [11] use an off-lattice single-cell-based model to examine how traits, such as proliferation and migration, are inherited by cells and alter the spatial and temporal heterogeneity of a growing tumour; Chang et al. [12] use a single-cell-based model to examine interactions between co-migrating tumour and stromal cells to study the emergence of collective movement. Finally, Basanta & Anderson [13] contribute the only review to this Theme Issue on the importance of viewing cancer from an ecological perspective. Using evolutionary game theory and cellular automata, they consider cancer as a disruption of the complex balance of many interacting cellular and microenvironmental elements in a specific organ. 
